• 中文核心期刊要目总览
  • 中国科技核心期刊
  • 中国科学引文数据库(CSCD)
  • 中国科技论文与引文数据库(CSTPCD)
  • 中国学术期刊文摘数据库(CSAD)
  • 中国学术期刊(网络版)(CNKI)
  • 中文科技期刊数据库
  • 万方数据知识服务平台
  • 中国超星期刊域出版平台
  • 国家科技学术期刊开放平台
  • 荷兰文摘与引文数据库(SCOPUS)
  • 日本科学技术振兴机构数据库(JST)

天然药物中的单体对脑缺血保护作用的实验研究进展

Progress on the protective effect of compounds from natural medicines on cerebral ischemia

  • 摘要: 天然药物治疗缺血性脑血管病历史悠久,积累了丰富的理论知识和治疗经验。综述近10年来天然药物中的单体成分,经复杂的病理生理机制,对脑缺血保护作用的实验研究,并选择其中代表性的16个单体按其病理生理机制分别介绍。天然药物保护缺血性脑损伤具有复杂的病理生理机制,主要通过降低兴奋性神经递质(银杏内酯B),抑制细胞凋亡(灯盏花素),影响星形胶质细胞活化和增殖(丹参酮Ⅱ A)及自由基(人参皂苷Rd),保护血脑屏障(黄芩苷)和减轻炎症反应(川芎嗪)等途径来实现,具有多靶点、多层次、多环节的脑保护作用。因此,研究天然药物单体通过脑缺血的病理生理机制中的各种途径来实现对缺血性脑损伤的保护作用,将有助于更好地治疗脑缺血患者和开发缺血性脑损伤保护作用的新制剂。

     

    Abstract: The treatment of cerebral ischemic disease by natural medicines has a long history,and has accumulated a rich theoretical knowledge and treatment experience.The objective of this review is to critically evaluate the experimental research situation of the protective effect of the individual compounds from natural medicine on cerebral ischemia in the past ten years,emphasizing the major mechanisms underlying cerebral ischemic pathophysiology.Sixteen representative compounds from natural medicines which are often used to treat stroke are discussed.The results indicate that these components possess a protective effect on cerebral ischemia,and that these components have different mechanisms,including inhibiting excitotoxicity by ginkgolide B,antiapoptosis of breviscapine,influencing astrocytic activation and proliferation of tanshinone IIA,influencing free radicals by ginsenoside Rd,impairing blood-brain barrier disruption by baicalin,and the anti-inflammatory activity of tetramethylpyrazine.Moreover,some components have multiple neuroprotective mechanisms.Therefore,the combination of individual compounds from natural medicines,considering the mechanisms of cerebral ischemia,may be beneficial to patients with cerebral ischemia in the future.This approach will provide a direction for the further application and exploitation of new drug development in the treatment of cerebral ischemia.

     

/

返回文章
返回